07:56 AM EST, 12/16/2024 (MT Newswires) -- Goldman Sachs' ( GS ) investment arm, Goldman Sachs Asset Management, has agreed to acquire drugmaker Synthon from private equity group BC Partners for more than 2 billion euro ($2.10 billion), the Financial Times reported Monday, citing people familiar with the matter.

Goldman Sachs ( GS ) did not immediately respond to a request for comment from MT Newswires.